Who we are

We take pride in every step of the process. From our organic grows to final product formulation we are committed to the highest quality.

Capital Markets Savvy with Strong Operational Expertise

Team

Franchise Cannabis has a management team and board that draw upon decades of experience in building successful corporate enterprises generating billions of dollars of shareholder value.

Board of Directors

Clifford Starke
President & CEO
Clifford Starke has over 10 years of experience financing and building high growth technology, pharma and cannabis companies. He has acted as a consultant, advisor or board member to a number of TSXV companies. Over the last four years, Mr. Starke has had success as an entrepreneur and dealmaker in the cannabis space and acted as a strategic advisor to multiple companies that have grown to become significant, highly valued, public enterprises.
Robert Cross
Chairman
Robert Cross has more than 25 years of experience as a financier and is currently the Chairman of B2Gold. He is a Co-Founder and Non-Executive Chairman of Bankers Petroleum Ltd., Co-Founder and Chairman of Petrodorado Energy Ltd., and until October 2007, was the Non-Executive Chairman of Northern Orion Resources Inc. Between 1996 and 1998, Mr. Cross was Chairman and Chief Executive Officer of Yorkton Securities Inc. From 1987 to 1994, he was a Partner, Investment Banking with Gordon Capital Corporation in Toronto. Mr. Cross has an Engineering Degree from the University of Waterloo and received his MBA from Harvard Business School in 1987.
Farhan Lalani
Director
Farhan Lalani is the Founder, President and CEO of Market One Media Group (MMG), Canada’s largest marketing agency catered towards the capital markets and public companies. MMG has a client roster with a combined market capitalization of over $10 billion dollars and is the country’s largest financial content creation and distribution engine leveraging relationships with Postmedia, Bell Media, and several other media outlets. Prior to launching MMG, Farhan worked in the capital markets industry with several brokerage firms most recently as an Investment Advisor and Partner at Leede Financial Markets. Among his recent achievements, Farhan was named as "Canada’s Next 150” by the TMX Group in 2017 and awarded the Forty under 40 award from Business In Vancouver in 2015.
Peter Simeon
Director
Peter Simeon is an experienced corporate commercial and securities lawyer. As a partner in Gowling WLG LLP’s Toronto office, Mr. Simeon has acted for clients across a range of industries from mining to technology, with a focus on cannabis. His expertise includes public offerings, including IPOs, RTOs, private placements, and qualifying transactions, bought deal financings, secondary offerings and share and asset purchase transactions. Mr. Simeon has served on the Board of Directors of three public cannabis companies, as well as numerous other non-cannabis public companies. In 2019, Peter was named one of Canada's "Top 25 Most Influential Lawyers" by Canadian Lawyer. Mr. Simeon has a Bachelor of Arts Degree in Political Studies from Queen’s University and a Law Degree from Osgoode Law School.
Nathan Shantz
Director
Nathan Shantz has over 8 years of experience working as a financier, entrepreneur, and capital markets professional. Mr. Shantz has extensive experience in the cannabis and health sciences space working in the capacity as an advisor and consultant, including as part of the founding team of a publicly listed Latin American focused cannabis oriented healthcare company. Prior to this, he worked at Macquarie Bank in the Natural Resources Private Equity Group focused on global investments in mining and oil & gas. Nathan is a graduate of the Honour’s Business Program at Wilfrid Laurier University in Waterloo, Ontario and is fluent in Spanish and Portuguese. He holds the Chartered Financial Analyst designation.

Executive Management

Clifford Starke
President & CEO
Clifford has 10 years of experience financing and building high growth technology, pharma and cannabis companies. He has acted as a consultant, advisor or board member to 18 companies and has successfully raised over $500m of capital. Over the last four years, Mr. Starke has had success as an entrepreneur and dealmaker in the cannabis space and acted as a strategic advisor to multiple companies that have grown to become significant, highly valued, public enterprises.
Nathan Shantz
CFO
Nathan Shantz has over 8 years of experience working as a financier, entrepreneur, and capital markets professional. Mr. Shantz has extensive experience in the cannabis and health sciences space working in the capacity as an advisor and consultant, including as part of the founding team of a publicly listed Latin American focused cannabis oriented healthcare company. Prior to this, he worked at Macquarie Bank in the Natural Resources Private Equity Group focused on global investments in mining and oil & gas. Nathan is a graduate of the Honour’s Business Program at Wilfrid Laurier University in Waterloo, Ontario and is fluent in Spanish and Portuguese. He holds the Chartered Financial Analyst designation.
Charles Scott
Head of Agriculture
Charles “the Reeferman” has been a thought leader in the cannabis breeding, genetics, and craft cultivation space for the past 28 years. He has won numerous globally recognized awards including 19 Cannabis Cups for THC strains such as Love Potion #1, Willie Nelson, and Pink Kush and his strains are used internationally. Charles has amassed a collection of strains from all over the world and has developed special strains with high CBD and auto-flowering properties. In 2007, Charles was inducted into the High Times Breeder Hall of Fame. Charles holds a Masters of Science degree at the University of Alberta.
Selcuk Copkayaoglu
Managing Director - Europe
Selcuk has over 15 years of experience driving high growth companies in the pharmaceutical Industry across European markets. He is an expert in business strategy and import/export regulations in Europe and maintains a wide network of wholesalers, manufacturers, and pharmacies. Most recently, he was the head of a €150MM annual turnover pharmaceutical distributor in Germany. Selcuk has also worked with a portfolio of leading pharmaceutical companies including Bayer, Novartis, Pfizer, Sanofi, Gilead, Sandoz, Astra Zeneca, Johnson & Johnson.